[go: up one dir, main page]

LARSON et al., 1945 - Google Patents

A comparison of the effect of thiouracil and of injected thyrotropic hormone on the collection of radioactive iodine and the anatomic changes induced in the thyroid of …

LARSON et al., 1945

Document ID
4817982796713576305
Author
LARSON R
KEATING F
Peacock W
RAWSON R
Publication year
Publication venue
Endocrinology

External Links

Snippet

Abstract MacKenzie and MacKenzie (1943) and Astwood and his associates (1943) found that certain drugs of the aniline and thiourea series produce marked hyperplasia of the thyroid of the rat associated with evidences of diminished thyroid function. The goitrogenic …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug

Similar Documents

Publication Publication Date Title
LARSON et al. A comparison of the effect of thiouracil and of injected thyrotropic hormone on the collection of radioactive iodine and the anatomic changes induced in the thyroid of the chick
Terkel et al. Maternal behavior induced by maternal blood plasma injected into virgin rats.
PAYNE Studies on the fat-mobilizing factor of the anterior pituitary gland
Tormey et al. Relation of thyroid function to acute and chronic effects of amphetamine in the rat
Hughes Cretinism in rats induced by thiouracil
MARTIN et al. Inhibition by apomorphine of prolactin secretion in patients with elevated serum prolactin
Larson et al. The effect of thiouracil on the collection of radioactive iodine by the thyroid of the chick
ENGEL On the nature of the interdependence of the adrenal cortex, non-specific stress and nutrition in the regulation of nitrogen metabolism
HELLER Another case of inhibition of ejaculation as a side effect of mellaril
Essig et al. Failure of diphenylhydantoin in preventing barbiturate withdrawal convulsions in the dog
Burn et al. Fall of blood pressure after a noradrenaline infusion and its treatment by pressor agents
Starr et al. Effect of oral thyroxine and tri-iodo-thyronine on radioactive iodine uptake and serum protein bound iodine in normal human subjects
Juhn et al. Molt of capon feathering with prolactin.
McIver Increased susceptibility to chloroform poisoning produced in the albino rat by injection of crystalline thyroxin
KAMIYOSHI et al. Augmentative effect of FSH on LH-induced ovulation in the hen
Thienpont et al. Propoxate (R 7464): a new potent anaesthetic agent in cold-blooded vertebrates
Cowie et al. Mammogenesis and lactogenesis in hypophysectomized, ovariectomized, adrenalectomized rats
Breneman RELATIVE EFFECTIVENESS OF ESTOSTERONE-PROPIONATE AND DIHYDROANDROSTERONE-BENZOATE IN THE CHICK AS INDICATED BY COMB GROWTH
Leonard et al. Effect of Male Hormone upon Uterine Motility and the Uterus.
Davis The production of experimental polycythemia by the daily administration of epinephrine or posterior pituitary solution
STRAUSS et al. The Duration of Remission in Pernicious Anemia with Liver Therapy: The Efficacy of Massive Doses Administered at One Time
Shevah A note on the use of dexamethasone for inducement of parturition of Finn× Dorset ewes
Grosvenor Effect of ergotamine on milk-ejection in lactating rat.
Prilusky et al. Inhibitory effect of prostaglandin F2α on oxytocin release and on milk ejection in lactating rats
Freyberg et al. Hypoparathyroidism: the treatment of chronic cases